IBSA UK & I, a global pharmaceutical company founded in Lugano in 1945, stands as a leader in the industry with a robust portfolio of 90 patent families and more in development. IBSA UK & I has 11 production sites producing 25 million hormone vials and 75 million finished product packs, spanning 10 therapeutic areas. An acquisition by current ownership in 1985, marked a pivotal shift in our vision and strategy, focusing on acquiring advanced technological resources to enhance the quality of therapeutic solutions and launching a comprehensive development program to consolidate our global expansion and asset development. With 20 subsidiaries across Europe, China, and the United States, IBSA UK & I is dedicated to improving patients' quality of life by researching and developing effective drugs and technologies that elevate existing therapeutic solutions.